illumicell AI (Techstars'23)

🌍 Discover the Future of Life Sciences at the Swiss Pavilion – BioJapan 2024! 🌟 We are thrilled to announce that Switzerland, a global leader in life sciences, will be showcasing its cutting-edge innovation at BioJapan 2024! Join us at the Swiss Pavilion, where groundbreaking technology companies, pioneering startups, and leading R&D institutions will gather to explore partnerships with Japanese companies. Together, we'll develop new technologies, drive next-generation growth, and build a sustainable future. 🗓 Event Details: 📅 October 9 (Wed) - 11 (Fri), 2024 ⏰ 10:00 - 17:00                                        📍 Pacifico Yokohama, Booth D-64 🚀 Meet Our Innovators: Lonza: Pioneering tools and services for life science research and biopharmaceutical manufacturing. Bachem Expert in peptide and oligonucleotide production for pharmaceuticals. CARBOGEN AMCIS: Specialists in drug development and commercialization. InSphero : Leader in 3D in vitro models for drug discovery. Perseo pharma AG: Innovator in gastrointestinal therapies and enzyme therapeutics. Global Antibiotic R&D Partnership (GARDP): Tackling drug-resistant infections with new treatments. Drugs for Neglected Diseases initiative - DNDi: Developing medicines for neglected diseases. PULSE - Modular Life Science Center: The Swuss multimodular innovation center for international biotech companies. CSEM: R&D Expert revolutionizing life sciences with miniaturization, integration and microengineering. Switzerland Innovation: Supporting Japanese tech-driven companies in their R&D activities by connecting talent, knowledge and expertise. 🌟 Spotlight on Swiss startups supported by Consulate of Switzerland, Swissnex in Japan: Nutrix AG.: Transforming chronic disease management with AI and remote monitoring. illumicell AI (Techstars'23): Using AI to enhance male fertility analysis. Adoram Therapeutics: Developing modulators for cancer and autoimmune diseases. Risklick: Optimizing clinical trial protocols with AI. Nanoflex Robotics : Advancing remote robotic solutions for endovascular treatments. Additionally, don't miss the Swiss Biotech Pitch Night on October 10, where Swiss deeptech startups will present their groundbreaking ideas to VCs and potential partners in an inspiring evening dedicated to innovation and collaboration. 👉 For more information, visit: https://lnkd.in/gc-HUjDd https://lnkd.in/dfYQTpDM This event is part of the #SwissVitalityDays and supported by the Embassy of Switzerland in Japan, Invest in Switzerland, and Switzerland Global Enterprise.#LifeSciences #Innovation #Biotechnology #Japan #Switzerland #Sustainability

#illumicelAI in #Japan 🇯🇵🇯🇵🇯🇵 Excited to participate in a series of events in Keihanna, Kyoto, Osake, Yokohama and Tokyo over the next two weeks 👇 Kyoto Smart City Expo  🗓️October 3-4 📍Keihanna Open Innovation Center As part of the KGAP+ accelerator, illumicell AI will be exhibiting and pitching at the #SmartCityKyoto. KGAP+ graduates, we will also present our progress and insights from the program. Plus, we will take the stage to share our vision for the future of #fertility care as we compete in the Keihanna Expo Global Startup Challenge – final round! The 21st Annual STS Forum 🗓️October 5-8 📍Kyoto International Conference Center Michel Bielecki MD MPH and Jeyla Sadikova will attend the STS Forum – a WEF-style event gathering leaders from academia, industry and government to address the pressing challenges that come with the advancement of technology. Michel Bielecki MD MPH will also join the #AIInHealthcare panel alongside Elias Zerhouni, Isaac Bentwich, Maria Hahn, Andrew Zachary Fire and Michinari Homoguchi. Pitch Apéro at Swissnex in Japan 🗓️October 8 📍Swissnex Office An invite-only networking event featuring dynamic startup pitches and short expert presentations, hosted by Consulate of Switzerland, Swissnex in Japan. Startups will present their inspiring visions and disruptive technologies, looking at the opportunities in Japan. BioJapan 2024 🗓️October 9-11 📍Pacifico Yokohama Meet us at the #Swiss Pavilion (D-64) for #BioJapan2024, Asia’s largest partnering event! Privileged to have been selected to represent #Switzerland, a consistent global leader in #LifeScienceInnovation. We’re excited to meet biotech companies and leading R&D institutions, and explore partnerships with Japanese companies. BioJapan / JTB Communication Design Techstars Tokyo visit 🗓️October 9 📍Techstars Tokyo Office As Techstars graduates, we’re excited to connect with the current Techstars Tokyo Accelerator cohort for an informal session to share our experiences navigating the entrepreneurial journey post-Techstars. Thanks Yuki Shirato for the invitation! Switzerland-Japan Economic Forum 2024  🗓️October 9 📍Tokyo Midtown Hall The Embassy of Switzerland in Japan and the Swiss Chamber of Commerce and Industry in Japan (SCCIJ) proudly present the 2024 Switzerland-Japan Economic Forum, supported by Keidanren (Japan Business Federation) and WIRED JAPAN. This event brings together business, academic and government leaders from both countries to showcase recent initiatives and highlight opportunities. Thanks Michael Mroczek for the invitation! Swiss Business Hub Japan Switzerland Global Enterprise Pitch Night at Ambassador’s Residence  🗓️October 10 📍The Residence of the Ambassador of Switzerland in Japan An apéro in honor of the Ambassador's visit to the Swiss Pavilion. This special event brings together innovators, diplomats and businesspeople – and a delightful touch of Swiss cheese and wine. Are you here, too? Let’s connect!

#STARTUP: 𝗦𝘄𝗶𝘀𝘀 𝗗𝗲𝗲𝗽𝘁𝗲𝗰𝗵 𝗥𝗼𝗮𝗱𝘀𝗵𝗼𝘄 𝗶𝗻 𝗝𝗮𝗽𝗮𝗻 🚀🇨🇭🇯🇵 Meet Startup Founders & CEOs! – From October 6-11, 2024, Swiss deep-tech startups will showcase their groundbreaking biotech and life sciences innovations in #Kyoto, #Osaka, #Yokohama, and #Tokyo. Join us to explore Swiss solutions with a global impact and discover the entrepreneurial spirit driving these transformative ventures. 🌟 Meet the Founders & CEOs:  David Pejoski  from Adoram Therapeutics,  Michel Bielecki MD MPH & Jeyla Sadikova from illumicell AI (Techstars'23),  Matt Curran from Nanoflex Robotics Maria Hahn from Nutrix AG, and Poorya Amini  from Risklick Explore the various stops on this exciting journey👇 𝗞𝘆𝗼𝘁𝗼: 𝗦𝘄𝗶𝘀𝘀 𝗦𝘁𝗮𝗿𝘁𝘂𝗽 𝗣𝗶𝘁𝗰𝗵𝗲𝘀 𝗮𝘁 𝗦𝗧𝗦 𝗙𝗼𝗿𝘂𝗺 🗓️ October 7, 2024 @10:10 am   📍 Room 103, Kyoto International Conference Center 𝗢𝘀𝗮𝗸𝗮: 𝗣𝗶𝘁𝗰𝗵 𝗔𝗽é𝗿𝗼 𝗮𝘁 𝗦𝘄𝗶𝘀𝘀𝗻𝗲𝘅 𝗶𝗻 𝗝𝗮𝗽𝗮𝗻 🗓️ October 8, 2024   📍 Consulate of Switzerland, Swissnex in Japan 𝗬𝗼𝗸𝗼𝗵𝗮𝗺𝗮: 𝗦𝘄𝗶𝘀𝘀 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗣𝗮𝘃𝗶𝗹𝗶𝗼𝗻 𝗮𝘁 𝗕𝗶𝗼𝗝𝗮𝗽𝗮𝗻 🗓️ October 9-11, 2024   📍 Pacifico Yokohama 𝗧𝗼𝗸𝘆𝗼: 𝗣𝗶𝘁𝗰𝗵 𝗡𝗶𝗴𝗵𝘁 𝗮𝘁 𝘁𝗵𝗲 𝗔𝗺𝗯𝗮𝘀𝘀𝗮𝗱𝗼𝗿’𝘀 𝗥𝗲𝘀𝗶𝗱𝗲𝗻𝗰𝗲 🗓️ October 10, 2024   📍 Ambassador’s Residence, Tokyo ℹ️ For more information, visit our website 👉 https://lnkd.in/gDjPiacu or reach out to Miki at miki.takashima@swissnex.org. We look forward to meeting you on this journey across Japan! Tatiana Benavides Damm Swiss Business Hub Japan Innosuisse Presence Switzerland Switzerland Global Enterprise #SwissTech #DeepTech #Biotech #LifeSciences #Japan #Swissnex #Entrepreneurship #SwissVitalityDays #STSforum #STSforum2024 #BioJapan #BioJapan2024 #SwissPavilion #SwissBiotechPavilion #Breakthrough Masatoshi Shoji, Felix Moesner Follow the Consulate of Switzerland, Swissnex in Japan🇨🇭🇯🇵 #AddingValue | #Education | #Research | #Innovation | #Startups🚀 | #VitalitySwiss

A brilliant Inc. Magazine article about innovation in #fertility and its intricate relationship with science and investors. Sam Blum sheds light on how innovation in fertility tech, supported by growing VC and PE investments, can provide affordable alternatives to costly #IVF treatments. The growing trend of direct-to-consumer solutions plays a big role in raising awareness about #ReproductiveHealth. However, as highlighted by experts like Brian A. Levine, MD, MS, FACOG, relying on these technologies may delay essential diagnosis and care, emphasizing the need for oversight and clinically validated tools in a booming market. At #illumicellAI, we are dedicated to clinical precision, ensuring our outcomes are based on scientific evidence and meet the standards for market approval. Our work is backed by leading fertility experts, guiding us in enhancing reproductive care not only during the most critical times but also well before the fertility journey begins. This is grounded in our core belief that fertility is not just one period of an individual's life, but a lifelong process that requires care and offers valuable insights into overall health. #fertilitytech #womenshealth #femtech

#illumicellAI co-founders Michel Bielecki MD MPH and Jeyla Sadikova presenting at LSI's recent #Medtech event in Sintra, Portugal. It was a privilege to share our vision for the future of #Fertility and to demonstrate our progress in achieving it. The conversations, insights and energy at the event were inspiring, and our team is excited about what’s next! #HealthcareAI #FertilityTech #WomensHealth LSI Europe Loup Cordey Anna Kuzmina Austin Lee Diana Maichin Carmen Messerlian Denis Vaughan, MD, FACOG, MRCPI Michael Eisenberg

illumicell AI (Techstars'23) (LSI Europe '24 Innovator) AI aims to make fertility testing vastly accessible, enabling early detection of potential issues. This helps men take proactive steps in addressing fertility issues, prevents women from unnecessary fertility treatments, and streamlines resources in fertility clinics. illumicell AI combines patented AI algorithms and microscopy technology to test 50x faster, and 20x more effectively, empowering every healthcare provider at the point of care – not just fertility clinics – with accessible, scalable fertility diagnostics. The team’s key milestones over the last 10 months include: • Raised a $1.3M pre-seed round, led by Brent Ahrens from Canaan Partners • Developed a POC prototype • Obtained promising preclinical data showcasing its accuracy in quantifying key male fertility parameters • Kicked off clinical trials at Fertas SA in Switzerland • Signed LOIs in USA, Switzerland, and Japan, with the leading fertility experts and urologists from Boston IVF, Harvard Chan, and Stanford Medicine among others • Filed a provisional patent for the system and its future applications • Graduated from prestigious accelerators including Harvard Innovation Labs, MassChallenge Boston, Techstars, and Creative Destruction Lab The company is preparing to raise a larger Seed round later this year to develop the final product, get a 510(k) FDA clearance, and kick off commercialization. We are excited to announce that illumicell AI co-founders, Michel Bielecki MD MPH and Jeyla Sadikova, have been selected to present at LSI Europe ‘24 this September 16-20th in Sintra, Portugal. Join us in Portugal to learn more about the future of fertility care.

Graduated from Creative Destruction Lab Toronto (#AI stream)! With about 30% graduation rate, illumicell AI (Techstars'23) became one of the finalists to complete CDL. During the Supersession in Toronto, we joined CDL graduates from all over the world. From our first session back in October [2023] that left me shattered to the festive Supersession, CDL has been a crucial catalyst for our progress, and I H I G H L Y recommend it to every tech/science founder: 👉Non-dilutive: CDL takes no equity or money 👉Sector-specific: Tailored to best fit your company’s industry 👉Remote friendly: It’s about the work you do, not where you are 👉Mentorship rich: Dozens of mentors from various fields 👉Competitive: Companies that fail to deliver are eliminated every two months 👉Supported for free by University of Toronto - Rotman School of Management MBA students: Heidi Wagner, MBA, PA’s industry expertise and Edison Zhu’s analytical skills were invaluable Here’s why I found CDL exceptional: 🗣️ Indirect Pitching We pitch to small groups of mentors who then pitch on our to dozens of others. The first pitch was an eye-opener; it was startling to see all the misunderstandings, especially since we were not allowed to intervene. We quickly realised it was crucial to make our pitch extremely simple. ♨️ Public Roast Think Tom Brady’s roast was rough?  These mentors provide raw, honest feedback — publicly. It can feel mean, but ultimately, it’s a learning curve. This initially unpleasant experience pushed us to fundamentally rethink our product development and business model. 🐩 Goal Grooming We are all guilty of setting delusional goals.  Thanks to our life sciences mentors, we were actively guided in setting goals appropriate for our stage and industry. During the Public Roasts, our progress was measured, and the goals were reviewed with a more diverse set of mentors. Mentors we initially thought were 'too generalist' ended up providing fresh perspectives we had overlooked. 👩⚖️ Up or Out If a company fails to reach its goals, it’s voted out, which I found thrilling. The goals felt more tangible and the spirit of competition stoked our ambition. Waiting to hear from the judges after each session felt like a suspenseful show cliffhanger, turning every win into a great team morale boost. Special thanks to Richard Foster, an emeritus senior partner at #McKinsey, who helped shape CDL and encouraged me to apply when we first met in NYC during illumicell AI's very early days. Thank you to the mentors who roasted us gently, groomed our goals and guided us through the jungle of knowledge:  James Hardiman, Igor Jurisica, Brent Norton, Dennis Bennie, Reza Zadeh, Joel Finlayson, Jamie Bruce 🫶 The staff: Kiara K., Ally MacDonald, Igor Cunha, PhD, Mathew Platt ❤️🩹 And to the team that absorbed the shock of each session to produce outputs that surpassed our own expectations: Michel Bielecki MD MPH, Loup Cordey, Javier Barranco Garcia, PhD, Anna Kuzmina

CDL is thrilled to present the complete list of the 250+ Graduating Ventures from the 2023/24 CDL Program year! Over the past year, high-potential startups from across the globe have been diligently working through the CDL program in diverse technology sectors. If you're a deeptech founder, applications for the upcoming program are open until July 26th! #BuildSomethingMassive Apply here: https://lnkd.in/ez43f-2

#STARTUP: 𝗣𝗶𝘁𝗰𝗵 𝗘𝘃𝗲𝗻𝘁 𝗞𝗚𝗔𝗣+ 🚀🇨🇭🇯🇵 Spotlight on Swiss innovation!🇨🇭 – We are excited to share the unveiling event of the 11th cohort of KGAP+ (Keihanna Global Acceleration Program Plus), a global startup support program organized by the ATR Innovation Co-Creation Team. KGAP+ supports domestic and international startups in their search for business partners. To date, 155 startups from 17 countries have participated in the program, boasting a 68% matching rate. This year, Batch 11 received entries from partner organizations worldwide, and 18 startups from 9 countries have been selected to participate, including 2 from #Switzerland that had joined the KGAP+ Pitch Contest on the stage of the Swisstech Pavillion at SusHi Tech Tokyo 2024 Global Startup Program Official Account. Congratulations to these two groundbreaking startups from Switzerland!🇨🇭🎊 Nutrix AG Nutrix innovates healthcare with its AI-powered SaaS platform and proprietary devices such as CortiSense, the first non-invasive cortisol sensor. Offering remote monitoring, personalized coaching, and tailored health programs for prevention and chronic disease management, Nutrix serves insurance companies, enterprises, and pharmacies, transforming patient care and outcomes globally. illumicell AI (Techstars'23) Illumicell AI transforms sperm testing by integrating a patented AI algorithm with a proprietary sensor system. The device uses AI to deliver lab-quality results with 98% accuracy, 50x faster and 20x cheaper than traditional methods. This innovation addresses fertility clinic bottlenecks, redefining male fertility diagnostics with unparalleled precision and efficiency. 𝗘𝘃𝗲𝗻𝘁 𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄 📅 𝗗𝗮𝘁𝗲 & 𝘁𝗶𝗺𝗲: July 12, 2024; 10:00-16:30 (Japan time - UTC +9)   📍 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺: Zoom 👉 𝗗𝗲𝘁𝗮𝗶𝗹 & 𝗥𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻: https://lnkd.in/gCad7adQ Don’t miss this exciting opportunity to discover the next big innovations! ✨ #SwissInnovation #Swisstech #Engineering #Sustainable #Future #Healthcare #Medical #Technology #ArtificialIntelligence #Fertility #InvestingOpportunity #Investing #STT2024GSP ATR Hiroyuki Suzuki JETRO - Japan External Trade Organization Presence Switzerland Swissnex Innovaud Switzerland Global Enterprise Swiss Business Hub Japan Science & Technology Office Tokyo Innosuisse Embassy of Switzerland in Japan Maria Hahn Michel Bielecki MD MPH Jeyla Sadikova Follow the Consulate of Switzerland, Swissnex in Japan🇨🇭🇯🇵 #AddingValue | #Education | #Research | #Innovation | #Startups🚀 | #VitalitySwiss

We are inspired by initiatives like Evvy's #EqualResearchDay, which highlight the #genderGap in healthcare. There are still many areas where women's health needs are not adequately addressed, and the #fertility sector is a prime example. For decades, women have shouldered the majority of responsibility when it comes to fertility treatments, enduring physically and emotionally taxing procedures. This disparity has not only negatively impacted women’s health but has also eroded any sense of male responsibility in the path to parenthood. We believe that fertility should be a shared journey, and that’s why #illumicellAI is dedicated to advancing #malefertility testing and diagnostics. At #illumicellAI, we are committed to changing this narrative by developing cutting-edge technologies that support men in their fertility journeys to complement their partners' and share the fertility responsibility. We are looking forward to contributing to Evvy knowledge and initiative in the upcoming years! See more insights by Evvy: https://lnkd.in/ez4cw58a #EqualResearchDay #HealthcareEquality #FertilityCare #fertilitytech Carmen Messerlian Diana Maichin Bill Standwill Michel Bielecki MD MPH Jeyla Sadikova Loup Cordey Anna Kuzmina